Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53
Open Access
- 26 September 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomasThe Journal of Pathology, 1997
- Phosphorylation of Bcl-2 Protein and Association with p21Ras in Ras-induced ApoptosisJournal of Biological Chemistry, 1996
- Prognostic value of bcl-2 expression in invasive breast cancerBritish Journal of Cancer, 1995
- The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor statusVirchows Archiv, 1994
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- Thymocyte apoptosis induced by p53-dependent and independent pathwaysNature, 1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Growth factors in development, transformation, and tumorigenesisCell, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- A Comparative Study of the Peroxidase-antiperoxidase Method and an Avidin-Biotin Complex Method for Studying Polypeptide Hormones with Radioimmunoassay AntibodiesAmerican Journal of Clinical Pathology, 1981